2026年6月最新影响因子数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
| 热门AI工具： |
论文引言生成
New
AI 写作痕迹检测
Hot
学术改写降重
论文摘要生成
参考文献挖掘工具
审稿意见辅助撰写
|
查看更多AI工具 >> |
| 近期推荐： | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS J PHARMACOL EXP THER （此期刊被最新的JCR期刊SCIE收录） LetPub评分 7.6
51人评分
我要评分
声誉 8.6 影响力 6.4 速度 9.6 | |||||||||||||||||||||
| 期刊ISSN | 0022-3565 | 安装APP，查看期刊最新消息
| ||||||||||||||||||||
| E-ISSN | 1521-0103 | |||||||||||||||||||||
| 2025-2026最新IF （数据来源于网友提供） | 注册或登录后，查看IF | |||||||||||||||||||||
| 实时影响因子 | 截止2026年9月20日：2.114 | |||||||||||||||||||||
| 2025-2026自引率 | 9.3%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年IF （数据来源于网友提供） | 3.604数据由网友[hiddencode864]收集提供 | |||||||||||||||||||||
| h-index | 209 | |||||||||||||||||||||
| CiteScore （ 2026年6月最新版） |
| |||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||
| 期刊官方网站 | http://jpet.aspetjournals.org/ | |||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
| 期刊投稿网址 | http://submit-jpet.aspetjournals.org/ | |||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Risk of liver adverse events with nivolumab/ipilimumab combination therapy for hepatocellular carcinoma: A disproportionality analysis based on the Food and Drug Administration Adverse Event Reporting System data base Author: Liu, Yujie; Yu, Hao; Wang, Yi; Xu, Changjing; Liang, Xuemei; Liu, Kezhi Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2026; Vol. 393, Issue 9, pp. -. DOI: 10.1016/j.jpet.2026.104994 Apatinib inhibits gastric cancer progression by inducing ferroptosis through cysteine dioxygenase 1/phosphoinositide 3-kinase/Akt axis Author: Li, Li-bin; Xu, Wen-ji Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2026; Vol. 393, Issue 8, pp. -. DOI: 10.1016/j.jpet.2026.104968 A novel NAD(P)H:quinone oxidoreductase 1-responsive vascular endothelial growth factor-targeted antibody-drug conjugate induces dual apoptosis and ferroptosis in glioblastoma S Author: Liu, Kai; Dong, Yuchao; Ren, Wei; Li, Dapeng; Wang, Zihao; Fan, Shiyong; Zong, Yuping; Ma, Chengyuan Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2026; Vol. 393, Issue 8, pp. -. DOI: 10.1016/j.jpet.2026.104974 Silencing thyroid hormone receptor interactor 13/kinetochore-associated 1 inhibits DNA damage repair and enhances Olaparib sensitivity in ovarian cancer Author: Guo, Xingzi; Tang, Jie; Li, He; Mao, Saiping; Tang, Yan-Xiang; Tang, Zhen-Zi; Gong, Lianghui Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2026; Vol. 393, Issue 8, pp. -. DOI: 10.1016/j.jpet.2026.104964 | |||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS的语言要求，还能让JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS编辑和审稿人得到更好的审稿体验，让稿件最大限度地被JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢（1篇） 。
提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||
| 通讯方式 | AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS, 9650 ROCKVILLE PIKE, BETHESDA, USA, MD, 20814-3995 | |||||||||||||||||||||
| 出版商 | American Society for Pharmacology and Experimental Therapeutics | |||||||||||||||||||||
| 涉及的研究方向 | 医学-药学 | |||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||||||
| 出版年份 | 1909 | |||||||||||||||||||||
| 年文章数 | 285点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 17.38% | |||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 88.42% | |||||||||||||||||||||
| WOS期刊JCR分区 （ 2025-2026年最新版） | 注册或登录后，查看WOS分区等级 | |||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||
  | ||||||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0022-3565%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 平均1.0个月 | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 约37.5% | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS顺利发表。
快看看作者怎么说吧：服务好评 论文致谢（1篇） 。 提交文稿 | |||||||||||||||||||||
| 期刊常用信息链接 | ||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Risk of liver adverse events with nivolumab/ipilimumab combination therapy for hepatocellular carcinoma: A disproportionality analysis based on the Food and Drug Administration Adverse Event Reporting System data base Author: Liu, Yujie; Yu, Hao; Wang, Yi; Xu, Changjing; Liang, Xuemei; Liu, Kezhi Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2026; Vol. 393, Issue 9, pp. -. DOI: 10.1016/j.jpet.2026.104994 PubMed DOI |
| 2. | Apatinib inhibits gastric cancer progression by inducing ferroptosis through cysteine dioxygenase 1/phosphoinositide 3-kinase/Akt axis Author: Li, Li-bin; Xu, Wen-ji Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2026; Vol. 393, Issue 8, pp. -. DOI: 10.1016/j.jpet.2026.104968 PubMed DOI |
| 3. | A novel NAD(P)H:quinone oxidoreductase 1-responsive vascular endothelial growth factor-targeted antibody-drug conjugate induces dual apoptosis and ferroptosis in glioblastoma S Author: Liu, Kai; Dong, Yuchao; Ren, Wei; Li, Dapeng; Wang, Zihao; Fan, Shiyong; Zong, Yuping; Ma, Chengyuan Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2026; Vol. 393, Issue 8, pp. -. DOI: 10.1016/j.jpet.2026.104974 PubMed DOI |
| 4. | Silencing thyroid hormone receptor interactor 13/kinetochore-associated 1 inhibits DNA damage repair and enhances Olaparib sensitivity in ovarian cancer Author: Guo, Xingzi; Tang, Jie; Li, He; Mao, Saiping; Tang, Yan-Xiang; Tang, Zhen-Zi; Gong, Lianghui Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2026; Vol. 393, Issue 8, pp. -. DOI: 10.1016/j.jpet.2026.104964 PubMed DOI |
| 5. | PRT-064040: A nasal spray of novel, potent, and selective calcitonin gene-related peptide receptor antagonist for migraine Author: Du, Shuwen; Yang, Hao; Yue, Jingmei; Wang, Hairong; Kou, Rui; Chen, Yashu; Liu, Chengran; Yang, Anle; Zhang, Dewei; Wang, Zhenyu Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2026; Vol. 393, Issue 8, pp. -. DOI: 10.1016/j.jpet.2026.104966 PubMed DOI |
| 6. | The intelectin 1-bestrophin-2-glutamate axis regulates glutamate homeostasis and suppresses colorectal cancer progression Author: Lu, Di; Zhou, Yang; Zhang, Han; Wang, Jiannan; Lu, Kai; Li, Yaonan; Guo, Cheng; Zhu, Yuanzeng Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2026; Vol. 393, Issue 7, pp. -. DOI: 10.1016/j.jpet.2026.104941 PubMed DOI |
| 7. | Exosomal miR-376c-3p derived from cardiac fibroblasts triggers cardiac hypertrophy by targeting ERP44 Author: Zhang, Yuexin; Hu, Xiaopei; Li, Jie; Jiang, Lujing; Huang, Junkai; Zhang, Bingsen; Ye, Jiantao Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2026; Vol. 393, Issue 7, pp. -. DOI: 10.1016/j.jpet.2026.104943 PubMed DOI |
| 8. | Artesunate does not prevent cardiac hypertrophy but inhibits heart failure progression in mice Author: Zhang, Anna; Yang, Guoling; Chu, Guojun; Hou, Zhiqi; Zhang, Yuefan; Yu, Yongsheng; Yi, Bo Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2026; Vol. 393, Issue 6, pp. -. DOI: 10.1016/j.jpet.2026.104938 PubMed DOI |
| 9. | Integrated network pharmacology and Mendelian randomization analysis to elucidate potential mechanisms of curcumin and resveratrol in myocardial infarction treatment Author: Zha, Chengqin; Weng, Minjie; Xu, Chunxia; Yuan, Yunyun; He, Yanzhen; Qi, Ying; Shi, Peijian; Shen, Xiangbo Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2026; Vol. 393, Issue 6, pp. -. DOI: 10.1016/j.jpet.2026.104898 PubMed DOI |
| 10. | Anti-inflammatory effect of deoxylapachol by regulating interleukin 17/Toll-like receptor/tumor necrosis factor signaling pathways Author: Wang, Yuxin; Xu, Liyan; Feng, Lixin; Zhao, Hanxue; Li, Fangzhen; Sik, Attila Gabor; Chen, Xiqiang; Liu, Kechun; Wang, Rongchun Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2026; Vol. 393, Issue 6, pp. -. DOI: 10.1016/j.jpet.2026.104897 PubMed DOI |
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共30条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
